생명과학 BPO 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 지역별 세분화 및 경쟁 구도(2020-2030년)
Life Sciences BPO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Services, By Region and Competition, 2020-2030F
상품코드:1878965
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 생명과학 BPO 시장은 2024년에 4,760억 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 9.10%로 성장하여 8,027억 2,000만 달러에 이를 것으로 예측됩니다.
생명과학 업무 프로세스 아웃소싱(BPO)은 제약, 생명공학, 의료기기 기업이 연구개발 지원에서 상업적 운영까지를 포함한 비핵심 업무를 외부 서비스 제공업체에 전략적으로 위탁하는 것을 말합니다. 이 시장의 성장은 주로 고정비를 변동비로 전환하고 자원 배분을 최적화하여 기업에 비용 효율성을 가져다 줄 필요성에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
4,760억 달러
시장 규모 : 2030년
8,027억 달러
CAGR : 2025-2030년
9.1%
성장 속도가 가장 빠른 부문
의약품 아웃소싱
최대 시장
아시아태평양
주요 시장 성장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 생명과학 BPO 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
서비스별(의약품 아웃소싱, 의료기기 아웃소싱, 계약 판매 및 마케팅 아웃소싱, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 생명과학 BPO 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 생명과학 BPO 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 생명과학 BPO 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 생명과학 BPO 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
남아프리카공화국
제10장 남미의 생명과학 BPO 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)
제품 출시
최근 동향
제13장 세계의 생명과학 BPO 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Atos SE
Boehringer Ingelheim International GmbH
Catalent Inc
Labcorp Early Development Laboratories Inc
ICON PLC
Infosys Ltd
International Business Machines Corporation(IBM)
Lonza Group AG
PAREXEL International Corp
IQVIA Inc
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
The Global Life Sciences BPO Market, valued at USD 476.00 Billion in 2024, is projected to experience a CAGR of 9.10% to reach USD 802.72 Billion by 2030. Life Sciences Business Process Outsourcing (BPO) encompasses the strategic delegation of non-core activities by pharmaceutical, biotechnology, and medical device companies to external service providers, covering functions from research and development support to commercial operations. This market's growth is primarily driven by the imperative for cost efficiency, enabling companies to convert fixed costs into variable ones and optimize resource allocation.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 476.00 Billion
Market Size 2030
USD 802.7 Billion
CAGR 2025-2030
9.1%
Fastest Growing Segment
Pharmaceutical Outsourcing
Largest Market
Asia Pacific
Key Market Drivers
The expansion of the Global Life Sciences BPO Market is largely propelled by the critical need for cost optimization and operational efficiency across the pharmaceutical, biotechnology, and medical device sectors. Companies in these industries increasingly leverage outsourcing to transform fixed overheads into variable costs, thereby enhancing financial agility and resource allocation. This strategic shift allows organizations to streamline non-core processes, such as administrative functions and certain support operations, which directly contributes to significant savings. For instance, according to Kelly Services, in 2023, a global pharmaceutical company achieved savings exceeding $1 million in its first year by adopting a specialized BPO administrative model. This highlights the tangible financial benefits realized through externalizing specific business processes.
Key Market Challenges
The inherent risk associated with data security and the protection of intellectual property directly impedes the growth of the Global Life Sciences BPO Market. Life sciences companies operate with highly sensitive and valuable data, including proprietary research and development information, clinical trial results, and confidential patient data. Entrusting this critical information to external service providers introduces significant vulnerabilities to potential data breaches, unauthorized access, or intellectual property theft. The profound reputational damage, regulatory penalties, and competitive disadvantages that can result from such incidents make organizations hesitant to extensively outsource core functions.
Key Market Trends
The increased adoption of AI and Machine Learning transforms life sciences BPO operations. These technologies enable providers to move towards intelligent automation, predictive analytics, and enhanced decision support, facilitating solutions like AI-driven pharmacovigilance and optimized clinical trial recruitment. This improves data processing speed and accuracy for complex data sets. According to The Pistoia Alliance, 68% of life science professionals surveyed in 2024 were already utilizing AI and machine learning, an increase from 54% in 2023. This trend reflects a clear commitment to leveraging AI for operational excellence. For instance, in August 2025, Cognizant launched its TriZetto AI Gateway, integrating its healthcare ecosystem with generative AI to advance healthcare delivery efficiency.
Key Market Players
Atos SE
Boehringer Ingelheim International GmbH
Catalent Inc
Labcorp Early Development Laboratories Inc
ICON PLC
Infosys Ltd
International Business Machines Corporation (IBM)
Lonza Group AG
PAREXEL International Corp
IQVIA Inc
Report Scope:
In this report, the Global Life Sciences BPO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Life Sciences BPO Market, By Services:
Pharmaceutical outsourcing
Medical devices outsourcing
Contract sales & market outsourcing
Others
Life Sciences BPO Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Life Sciences BPO Market.
Available Customizations:
Global Life Sciences BPO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Life Sciences BPO Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Services (Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales & market outsourcing, Others)
5.2.2. By Region
5.2.3. By Company (2024)
5.3. Market Map
6. North America Life Sciences BPO Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Services
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Life Sciences BPO Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Services
6.3.2. Canada Life Sciences BPO Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Services
6.3.3. Mexico Life Sciences BPO Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Services
7. Europe Life Sciences BPO Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Services
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Life Sciences BPO Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Services
7.3.2. France Life Sciences BPO Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Services
7.3.3. United Kingdom Life Sciences BPO Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Services
7.3.4. Italy Life Sciences BPO Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Services
7.3.5. Spain Life Sciences BPO Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Services
8. Asia Pacific Life Sciences BPO Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Services
8.2.2. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Life Sciences BPO Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Services
8.3.2. India Life Sciences BPO Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Services
8.3.3. Japan Life Sciences BPO Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Services
8.3.4. South Korea Life Sciences BPO Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Services
8.3.5. Australia Life Sciences BPO Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Services
9. Middle East & Africa Life Sciences BPO Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Services
9.2.2. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Life Sciences BPO Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Services
9.3.2. UAE Life Sciences BPO Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Services
9.3.3. South Africa Life Sciences BPO Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Services
10. South America Life Sciences BPO Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Services
10.2.2. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Life Sciences BPO Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Services
10.3.2. Colombia Life Sciences BPO Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Services
10.3.3. Argentina Life Sciences BPO Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Services
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Life Sciences BPO Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Atos SE
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Boehringer Ingelheim International GmbH
15.3. Catalent Inc
15.4. Labcorp Early Development Laboratories Inc
15.5. ICON PLC
15.6. Infosys Ltd
15.7. International Business Machines Corporation (IBM)
